DE1493031A1 - 1-Isopropyliden-4-(alpha-carboxyisopropyl)-semicarbazid und Verfahren zu dessen Herstellung - Google Patents
1-Isopropyliden-4-(alpha-carboxyisopropyl)-semicarbazid und Verfahren zu dessen HerstellungInfo
- Publication number
- DE1493031A1 DE1493031A1 DE19651493031 DE1493031A DE1493031A1 DE 1493031 A1 DE1493031 A1 DE 1493031A1 DE 19651493031 DE19651493031 DE 19651493031 DE 1493031 A DE1493031 A DE 1493031A DE 1493031 A1 DE1493031 A1 DE 1493031A1
- Authority
- DE
- Germany
- Prior art keywords
- semicarbazide
- isopropylidene
- preparation
- combination
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 3
- SOOKOQNALPJUOJ-UHFFFAOYSA-N 2-methyl-2-[(propan-2-ylideneamino)carbamoylamino]propanoic acid Chemical compound C(C)(C)=NNC(=O)NC(C)(C)C(=O)O SOOKOQNALPJUOJ-UHFFFAOYSA-N 0.000 title description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 210000004185 liver Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- -1 1-isopropylidene-4- (α-carboxypropyl) semicarbazide Chemical compound 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GHAFORRTMVIXHS-UHFFFAOYSA-L bromosulfophthalein sodium Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(O)=CC=C1C1(C=2C=C(C(O)=CC=2)S([O-])(=O)=O)C(C(Br)=C(Br)C(Br)=C2Br)=C2C(=O)O1 GHAFORRTMVIXHS-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- UJTTUOLQLCQZEA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(4-hydroxybutyl)carbamate Chemical compound C1=CC=C2C(COC(=O)NCCCCO)C3=CC=CC=C3C2=C1 UJTTUOLQLCQZEA-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
- C07C281/08—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
- C07C281/10—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being further bound to an acyclic carbon atom or to a carbon atom of a ring other than a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DES0095864 | 1965-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1493031A1 true DE1493031A1 (de) | 1968-12-12 |
Family
ID=7519662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19651493031 Pending DE1493031A1 (de) | 1965-03-10 | 1965-03-10 | 1-Isopropyliden-4-(alpha-carboxyisopropyl)-semicarbazid und Verfahren zu dessen Herstellung |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE1493031A1 (enrdf_load_stackoverflow) |
| FR (1) | FR4597M (enrdf_load_stackoverflow) |
| GB (1) | GB1043339A (enrdf_load_stackoverflow) |
-
1965
- 1965-03-10 DE DE19651493031 patent/DE1493031A1/de active Pending
- 1965-08-25 GB GB36536/65A patent/GB1043339A/en not_active Expired
- 1965-09-17 FR FR31826A patent/FR4597M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR4597M (enrdf_load_stackoverflow) | 1966-11-14 |
| GB1043339A (en) | 1966-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2659152A1 (de) | Neue antibiotische praeparate zur pharmazeutischen verwendung | |
| DE3130912A1 (de) | Analgetische arzneimittelkombination | |
| DE1795711B2 (de) | Substituierte Benzimidazole, Verfahren zu deren Herstellung sowie diese enthaltende anthelminthische Zusammensetzungen | |
| DE1493031A1 (de) | 1-Isopropyliden-4-(alpha-carboxyisopropyl)-semicarbazid und Verfahren zu dessen Herstellung | |
| EP0084516B1 (de) | Anthelmintika | |
| DE2736508A1 (de) | Tiermedizinische zubereitungen gegen helminthen | |
| EP0242559A2 (de) | Verwendung aminosubstituierter Benzoesäuren als Heilmittel gegen Diarrhoe und Arzneimittel auf Basis dieser Verbindungen | |
| DE2314387C3 (de) | Arzneimittel zur Behandlung bösartiger Neubildungen | |
| CH634302A5 (de) | Verfahren zur herstellung neuer mercaptomethylpyridin-derivate. | |
| DE1793769C2 (de) | Verfahren zur Herstellung von Bis-(thiosemicarbazonen). Ausscheidung aus: 151205 | |
| DE1767540C2 (de) | Mittel zur Behandlung von Histomoniasis bei der Geflügelzucht | |
| DE69200794T2 (de) | Verwendung von 4,9,11-Trien-Steroiden in Zusammensetzungen für Truthühner. | |
| DE1792758C2 (de) | Mittel gegen Leberegel. Ausscheidung aus: 1543792 | |
| DE2413803A1 (de) | Pharmazeutische zusammensetzungen aus gemischten salzen von sulfoglykopeptiden mit metallbasen und organischen basen | |
| DE964326C (de) | Verfahren zur Herstellung von Derivaten des 4-Oxycumarins | |
| DE1543792C (de) | Monophosphorsäureester von 2,2 Biphenolen sowie Verfahren zu ihrer Her stellung | |
| DE2201123A1 (de) | Verfahren zur Herstellung von neuen Rutin-Komplexverbindungen | |
| AT213395B (de) | Verfahren zur Herstellung des neuen β-Hydroxybuttersäure-cyclohexylamids | |
| DE2431093C2 (de) | 1-Carbamoyl-5(6)-sulfinyl-substituierte Benzimidazol-2-carbaminsäuremethylester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE1920673C (de) | Arzneimittel mit cholagoger Wirkung | |
| AT236406B (de) | Verfahren zur Herstellung von neuen Azidobenzolsulfonylharnstoffen | |
| DE1518443C (de) | 2-(2,6-Dimethoxyphenoxyäthyl)-aminomethyl-l,4-benzodioxan und dessen Hydrochlorid sowie Verfahren zu deren Herstellung | |
| DE2211419A1 (de) | Penicilloinsaurederivate | |
| DE1935986A1 (de) | Neue anthelminthische Verbindungen | |
| DE1252696B (de) | Verfahren zur Herstellung von Säureadditionssalzen basisch substituierter 4,5-Dihydrofurane |